Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BRTX-100
- Development stage
- Phase 2
- Lead developer
- BioRestorative Therapies
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intradiscal
01
Overview
BRTX-100 is an autologous mesenchymal stem cell (MSC) therapy developed by BioRestorative Therapies for the treatment of chronic discogenic pain. The therapy involves harvesting a patient's own stem cells, which are then processed and injected into the affected intervertebral disc to promote tissue regeneration and reduce inflammation. BRTX-100 is currently in Phase 2 clinical trials for chronic lumbar disc disease, for which it has received FDA Fast Track designation. The company has also received Investigational New Drug (IND) clearance to expand the clinical program to include chronic cervical discogenic pain. Additionally, BioRestorative is collaborating with Washington University of St. Louis under an NIH grant to evaluate the therapeutic effects of BRTX-100 when encapsulated in a PEG-peptide hydrogel.
- Brand names
- ReJoin
- Other names
- Autologous mesenchymal stem cellsCultured bone marrow-derived mesenchymal stem cells
Beyond the preview
Go deeper on BRTX-100.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BRTX-100.